» Articles » PMID: 31133052

Efficacy of Post-procedural Oral Hydration Volume on Risk of Contrast-induced Acute Kidney Injury Following Primary Percutaneous Coronary Intervention: Study Protocol for a Randomized Controlled Trial

Overview
Journal Trials
Publisher Biomed Central
Date 2019 May 29
PMID 31133052
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Contrast-induced acute kidney injury (CI-AKI) contributes toward unfavorable clinical outcomes. Oral hydration with water is inexpensive and it may be effective in the prevention of CI-AKI, but its efficacy among patients undergoing primary percutaneous coronary intervention (PCI) remains unknown.

Methods/design: Our study is a secondary analysis on the database from the ATTEMPT study. We enrolled ST-elevation myocardial infarction (STEMI) patients undergoing primary PCI. Eligible patients received peri-procedural aggressive (left ventricular end-diastolic pressure-guided) or routine (≤ 500 mL) intravenous hydration with an isotonic solution (0.9% NaCl) with randomization. The primary endpoint was CI-AKI, defined as a > 25% or 0.5 mg/dL increase in serum creatinine from baseline during the first 48-72 h post-procedurally. All patients drank unrestricted amounts of fluids freely, the volume of which was recorded until 24 h following primary PCI. Oral hydration volume/weight (OHV/W) ratios were calculated. The association between post-procedural oral hydration (quartiles) and CI-AKI was assessed using multivariable analysis controlling for confounders, including intravenous hydration strategies.

Discussion: Our study determined the effects of post-procedural oral hydration on CI-AKI following primary PCI, which is a potential strategy for CI-AKI prevention among patients with STEMI at very high risk.

Trial Registration: ClinicalTrials.gov, NCT02067195 . Registered on 21 February 2014.

Citing Articles

Effectiveness of Oral Hydration in Preventing Contrast-Induced Nephropathy in Individuals Undergoing Elective Coronary Interventions.

Pioli M, Couto R, Francisco J, Antoniassi D, Souza C, Olivio M Arq Bras Cardiol. 2023; 120(2):e20220529.

PMID: 36856244 PMC: 9972663. DOI: 10.36660/abc.20220529.

References
1.
Taylor A, Hotchkiss D, Morse R, McCabe J . PREPARED: Preparation for Angiography in Renal Dysfunction: a randomized trial of inpatient vs outpatient hydration protocols for cardiac catheterization in mild-to-moderate renal dysfunction. Chest. 1999; 114(6):1570-4. DOI: 10.1378/chest.114.6.1570. View

2.
McCullough P, Wolyn R, Rocher L, Levin R, ONeill W . Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. Am J Med. 1997; 103(5):368-75. DOI: 10.1016/s0002-9343(97)00150-2. View

3.
Hiremath S, Akbari A, Shabana W, Fergusson D, Knoll G . Prevention of contrast-induced acute kidney injury: is simple oral hydration similar to intravenous? A systematic review of the evidence. PLoS One. 2013; 8(3):e60009. PMC: 3608617. DOI: 10.1371/journal.pone.0060009. View

4.
Sgura F, Bertelli L, Monopoli D, Leuzzi C, Guerri E, Sparta I . Mehran contrast-induced nephropathy risk score predicts short- and long-term clinical outcomes in patients with ST-elevation-myocardial infarction. Circ Cardiovasc Interv. 2010; 3(5):491-8. DOI: 10.1161/CIRCINTERVENTIONS.110.955310. View

5.
Zoungas S, Ninomiya T, Huxley R, Cass A, Jardine M, Gallagher M . Systematic review: sodium bicarbonate treatment regimens for the prevention of contrast-induced nephropathy. Ann Intern Med. 2009; 151(9):631-8. DOI: 10.7326/0003-4819-151-9-200911030-00008. View